Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1430 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Avacta gets order for Optim 1000 system

Avacta claimed that Optim fills a significant gap in the market by providing detailed analysis using only very small sample volumes, and also enables drug developers to gain

AstraZeneca revenues fall in Q3

Revenue in markets outside the US increased by 7%, including a 14% increase in Emerging Markets. Revenue in Western Europe was up 3%. Revenue in Established Rest of